Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Maptech Holdings Ug has 1 pending office action within the Biotechnology & Pharmaceuticals sector. This activity is distributed among 1 distinct examiner and 1 distinct art unit. The portfolio's current state reflects a highly specialized focus, with all active prosecution occurring within a single technical silo. This arrangement simplifies the management of deadlines but increases the impact of any single procedural or substantive rejection from the USPTO.
JOHNSON, KARA D is the busiest examiner for the company, managing 1 busiest examiner pending office action. This individual handles the 1 pending office action currently active for the entity. In the Biotechnology & Pharmaceuticals field, where examiner discretion can be significant, having only one point of contact requires a highly focused advocacy strategy. The legal team must align their arguments specifically with the prior art interpretations favored by JOHNSON, KARA D.
The involvement of 1 distinct art unit suggests that the company's current intellectual property interests are confined to a specific niche. With 1 pending office action total, there is no opportunity to leverage different examiner perspectives across the portfolio. Success depends on a successful resolution with the current examiner to move the portfolio toward allowance. The 1 distinct examiner and 1 distinct art unit define the current boundaries of the company's patent strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOHNSON, KARA D | 1 | 69.5% | +24.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17835243 | EXTRACELLULAR MATRICES WHICH CAN BE USED AS SCAFFOLD FOR LIVING CELLS | JOHNSON, KARA D | 33d |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17835243 | EXTRACELLULAR MATRICES WHICH CAN BE USED AS SCAFFOLD FOR LIVING CELLS | JOHNSON, KARA D | 1632 | §103Other | Final Rejection | 33d | Pending | Jun 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial